EADV Congress 2024 Amsterdam
We thank each and every one who contributed to the overwhelming success of this year’s Congress. Featuring over 650 speakers from 50+ countries who conducted 180+ sessions, which drew an engaged audience of more than 17,000 delegates worldwide, your combined dedication has truly elevated this event to new heights.


Unveiling the Pathomechanism of Behçet’s Disease
EADV funded
Behçet’s disease (BD) is a chronic, relapsing multisystemic vasculitis that typically affects individuals in their 30s and 40s, leading to significant morbidity. Its pathogenesis remains enigmatic, shaped by complex genetic, environmental, autoimmune, and autoinflammatory factors.


Skin and sexually transmitted infections and health promotion strategy in migrant populations in Malta and Lebanon
EADV funded
The SSKAPP project promotes skin disease and STI education among migrants in Malta and Lebanon, using teledermatology and outreach clinics. It served over 3,200 migrants in Malta and diagnosed 598 cases in Lebanon, while training healthcare providers and supporting refugee care.


Tumour-specific antibodies able to detect melanoma in its earliest stages, new study shows
EADV Press Release
Innovative research has unveiled promising advancements in melanoma detection, which could significantly enhance diagnosis and prognosis by identifying the disease at its earliest, most treatable stages.


New research confirms link between perceived stress and psoriasis relapse
EADV Press Release
Innovative research has provided compelling evidence that perceived stress can directly trigger the relapse of psoriatic skin lesions.


Breakthrough research identifies new targets for wound healing
EADV Press Release
Novel research has identified key molecular targets that could significantly enhance the healing of both acute and chronic wounds.


Semaglutide improves outcomes for obese patients with common skin condition, new study shows
EADV Press Release
A pioneering study demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in people with obesity.